Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 4Phase 3 4Phase 2 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Endocrine 3

Conditions

Pituitary Neoplasms 2Prolactinoma 1Pituitary ACTH Hypersecretion 1Hyperprolactinemia 1Adenoma 1ACTH-Secreting Pituitary Adenoma 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Cabergoline × Clear all
NCT07463235 2026-03-13

SPARAGMOS

University of Sao Paulo General Hospital

Phase 3 Recruiting
70 enrolled

Hyperprolactinemia, Prolactinoma

NCT02288962 2025-06-08

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

St. Olavs Hospital

Phase 3 Active not recruiting
60 enrolled
Endocrine

Adenoma, Pituitary Neoplasms

NCT03271918 2017-09-07

Cabergoline in Nonfunctioning Pituitary Adenomas

University of Sao Paulo General Hospital

Phase 3 Completed
140 enrolled
Endocrine

Pituitary Neoplasms

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Seth Gordhandas Sunderdas Medical College

Phase 3 Completed
Endocrine

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡